Drugs

, Volume 50, Supplement 1, pp 37–40 | Cite as

Combination Therapy with Cyclosporin in Rheumatoid Arthritis

  • David E. Yocum
Article

Summary

During the last few years, there have been rapid developments in the drug treatment of rheumatoid arthritis. This has led to research into the role of combination therapy. While past combinations of slow-acting antirheumatic drugs have resulted in either an excessive number of adverse events or a lack of increased efficacy over single agent therapy, newer combinations appear to be more promising. It has recently been demonstrated that the combination of cyclosporin and methotrexate is more effective than methotrexate alone, with no increase in adverse effects. Improved trial methodology and a better understanding of the mechanism of action of these newer agents are assisting in the development of new combinations.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amor B, Herson D, Cherot A, et al. Follow-up study of patients with rheumatoid arthritis over a period of more than 10 years (1966–1978): analysis of disease progression and treatment in 100 cases. Ann Med Interne 1981; 132: 168–73.Google Scholar
  2. 2.
    Williams HJ, Willkens RF, Samuelson CO, et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985; 28: 721–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Choy EHS, Scott DL. Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies: new perspectives. Drugs 1995; 50 Suppl. 1: 15–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Tiliakos NA. Low-dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: two years later [abstract] Arthritis Rheum 1986; 29: S79.Google Scholar
  5. 5.
    Bunch TW, O’Duffy JD, Tompkins RB, et al. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984; 27(3): 267–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Csuka M, Carreara GF, McCarty DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, aza-thioprine and hydroxychloroquine: a follow-up study. JAMA 1986; 255: 2315–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Biro JA, Segal AM, MacKenzie AH, et al. The combination of methotrexate and azathioprine for resistant rheumatoid arthritis [abstract] Arthritis Rheum 1987; 30: S18.CrossRefGoogle Scholar
  8. 8.
    Willkens RF, Urowits MB, Stablei DM, et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1992; 35: 849–56.PubMedCrossRefGoogle Scholar
  9. 9.
    Haagsma C, Van Riel P, deRooij DJ, et al. Combination therapy in RA: sulphasalazine and methotrexate [abstract] Arthritis Rheum 1993; 36: S53.Google Scholar
  10. 10.
    O’Dell J, Haire C, Erikson N, et al. Triple DMARD therapy for rheumatoid arthritis: efficacy [abstract] Arthritis Rheum 1994; 37: S295.Google Scholar
  11. 11.
    Sigal NH, Dumont FJ. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol 1992; 10: 519–60.CrossRefGoogle Scholar
  12. 12.
    Segal R, Mozes E, Yaron M, et al. The effects of methotrexate on the production and activity of interleukin-I. Arthritis Rheum 1989; 32: 370–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Brahn E, Peacock DJ, Banquerigo ML. Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. Arthritis Rheum 1991; 34: 1282–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Bensen W, Tugwell P, Roberts R, et al. Combination therapy of cyclosporin with methotrexate and gold in rheumatoid arthritis (2 pilot studies) [abstract] Arthritis Rheum 1994; 37: S335.Google Scholar
  15. 15.
    Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Stein CM, Pincus T, Brooks RH, et al. Combination therapy with cyclosporin and methotrexate: results of a 24 week extension study subsequent to a 24 week double-blind study [abstract] Arthritis Rheum 1994; 37: S252.Google Scholar
  17. 17.
    Landewé RBM, Miltenburg AMM, Breedveld FC, et al. Cyclosporin and chloroquine synergistically inhibit the interferon gamma production by CD4-positive and CD8-positive synovial T cell clones derived from a patient with rheumatoid arthritis. Cyclosporin in RA 1994; 111-23Google Scholar
  18. 18.
    Landewé RBM, Miltenburg AMM, Verdonk MJA, et al. Cyclosporin and chloroquine synergistically inhibit T cell proliferation by interference with IL-2 production and IL-2 responsiveness. Cyclosporin in RA 1994; 125-46Google Scholar
  19. 19.
    Herzog C, Walker C, Muller W, et al. Anti-CD4+ antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical and circulating T cells. J Autoimmun 1989; 2: 627–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Cush JJ, Kavanaugh AF. Biologic intervention in rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 797–816.PubMedGoogle Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  • David E. Yocum
    • 1
  1. 1.Department of Medicine, Arizona Arthritis CenterUniversity of ArizonaTucsonUSA

Personalised recommendations